Flow cytometry is a biophysical, laser based analytical technology that measures and analyses several physical characteristics of cells or particles suspended in a fluid, when passed through a laser beam. Flow cytometry has various advantages over traditional analytical methods such as ELISA, which include its ability to deliver precise and accurate results and lesser time consumption at about same prices. The flow cytometry technology is widely used in the various fields of academic and clinical research, and diagnosis of diseases such as cancer, HIV and hematological malignancies. Rising count of patients suffering from HIV and cancer and increasing use of flow cytometry in hospitals and diagnostic centers, has created an impending need of flow cytometry in the effective diagnosis and monitoring of diseases. The term flow cytometry as well as fluorescence-activated cell sorting are often interchangeable. FACS or fluorescence activated cell sorting used in flow cytometry have kept the market future
World flow cytometry market is set to grow at a remarkable pace in the coming years, attributed to technological advancements and high adoption in various research and diagnostic applications. In addition, the advent of flow cytometry technology in novel research applications such as cytogenomics, proteomics and marine biology would further supplement the industry growth. Further, rising incidence rates of diseases such as cancer and HIV are likely to boost the adoption of flow cytometry technology across diagnostic applications. On the other hand, factors such as high cost associated with instruments and reagents, lack of awareness among potential end users and the limited availability of technical expertise are likely to impede the market growth. The preference of flow cytometry in drug discovery & development and diagnostics is expected to provide numerous growth opportunities.
The world flow cytometry market is estimated to reach $7.0 billion by 2022, registering a CAGR of 16.0% over the forecast period. The report segments the world flow cytometry market based on components, technologies, applications, end users and geography. Based on components, the market is segmented into instruments, reagents, software and services. Instruments accounted for the highest revenue-generating segment in 2014, owing to the technological advancements, demand for highly efficient replaceable components and widening scope of flow cytometry applications in newer diseases. Based on technology, the market is segmented into bead based and cell based technologies. Cell based flow cytometry would constitute the highest revenue generating segment throughout the forecast period due to its widespread use across all the applications. Based on application, world flow cytometry market is segmented into academic and clinical research, and diagnostic applications. Academic and clinical research application was the major revenue generating segment in 2014, however, diagnostics segment is projected as the fastest growing segment. The world flow cytometry end users market is segmented into commercial organizations, medical schools and labs, hospitals, academics and others. Commercial organizations were the highest revenue generating end-user segment in 2014, due to high adoption of flow cytometry in drug discovery process and clinical research.
Based on geography, the market is segmented across North America, Europe, Asia-Pacific and LAMEA. North America was the leading region in 2014, supplemented by rapid technological advancements, high R&D investment and widespread use of flow cytometry in diagnostic activities. Asia Pacific region would emerge as the most lucrative market over the forecast period owing to outsourcing of R&D activities in this region and increasing incidences of diseases such as cancer and HIV.
The report provides a comprehensive analysis of the leading companies operating in the world flow cytometry market. Key companies profiled in the report are Danaher Corporation (Beckman Coulter), Becton, Dickinson and Company, EMD Millipore, Sysmex Corporation, Affymetix Inc., Luminex Corporation, Thermo Fischer Scientific, Bio-Rad Laboratories, Inc., Miltenyi Biotec, Inc. and Agilent Technologies, Inc.
FLOW CYTOMETRY MARKET KEY BENEFITS:
The study provides an in-depth analysis of the world clinical flow cytometry market share, size with current and future trends to elucidate the imminent investment pockets in the market.
The report provides a quantitative analysis through 2014-2022, which would enable the stakeholders to capitalize on prevailing market opportunities.
Extensive analysis of the world flow cytometry market, by component, helps in understanding the components of the flow cytometer that are currently used along with the variants that would gain prominence in the future.
Complete overview of Competitive intelligence highlights the business practices followed by leading market players across various geographies.
SWOT analysis enables to study the internal and external environment of the leading companies for strategy formulation.
The Global neuromodulation market size is expected to reach $11,717 million by 2022, registering a CAGR of 13.1% from 2016 to 2022 Neurological disorders such as epilepsy, Alzheimer disease, cerebrovascular diseases, and Parkinson's disease affect the central and peripheral nervous system.
High prevalence of chronic diseases and growing healthcare awareness has boosted the market growth for neuroprosthetic devices/implants. This research report provides pin-point analysis of the global neuroprosthetics market, including market estimates and trends through 2020. The report contains an in-depth analysis of different segments such as neuroprosthetics technologies, types, applications and geography.
Synthetic biology is a novel area of research that is the amalgamation of multiple disciplines such as molecular biology, biotechnology, biophysics and genetic engineering among others. There are chiefly two approaches used in synthetic biology namely, top down approach and bottom up approach.
Synthetic biology is a novel field that finds its origin at the intersection of biology and engineering. It involves designing and construction of biological systems or devices that can be applied in varied domains to get specified results. Its a multidisciplinary effort made by scientists to understand the functioning of biological organisms, cells & genes and implementation of artificial genetic processes to give specific characteristics to an organism. It can even be used to develop a completely new biological system. Global synthetic biology market was valued at $3.0 billion in 2013 and it is estimated to reach $38.7 billion by 2020, growing at a CAGR of 44.2% during the forecast period.
Immunoprotein is a protein with immunological activity, which provides immunity against pathogenic organisms or substances. Immunoproteins form the integrated body system of tissues, organs, cells or cell products that neutralizes antigens. These proteins enable the diagnosis of various diseases as they display an abnormal increase in their blood concentration when in a diseased state. High prevalence of cancers, cardiovascular diseases, allergies, urological disorders and orthopaedic diseases are the major drivers of the global immunoprotein diagnostic testing market.
The global melanoma market has witnessed an unprecedented boost in market size, owing to a dynamically evolving nature of melanoma treatments over the past few years. The high demand of novel early stage and advanced melanoma therapies along with a booming patient base, has created an impending need for better therapies in the melanoma market. Although, a plethora of treatment options are available today, several immunotherapies and combination therapies ar